Structure Therapeutics Inc.
GPCR
$56.65
$2.905.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 18.74% | -5.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -118.62% | 4.74% | |||
| Operating Income | 118.62% | -4.74% | |||
| Income Before Tax | 150.57% | -6.64% | |||
| Income Tax Expenses | 57.41% | -22.30% | |||
| Earnings from Continuing Operations | 150.23% | -6.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 150.23% | -6.57% | |||
| EBIT | 118.62% | -4.74% | |||
| EBITDA | 119.72% | -4.63% | |||
| EPS Basic | 146.34% | -4.85% | |||
| Normalized Basic EPS | 150.29% | -4.92% | |||
| EPS Diluted | 146.34% | -4.85% | |||
| Normalized Diluted EPS | 150.29% | -4.92% | |||
| Average Basic Shares Outstanding | 8.38% | 1.63% | |||
| Average Diluted Shares Outstanding | 8.38% | 1.63% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||